Amedeo Smart

Free Medical Literature Service




  Free Subscription


2 Ann Intern Med
4 Clin Infect Dis
12 J Infect Dis
3 J Virol
1 Lancet
5 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Immunol
1 Nat Med
1 Pediatrics
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
22 Vaccine
1 Virus Res


  1. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.
    >> Share

    Ann Intern Med

  2. DEEPAK P, Kim W, Paley MA, Yang M, et al
    Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-1757.
    >> Share

  3. BILINSKI A, Salomon JA, Giardina J, Ciaranello A, et al
    Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies.
    Ann Intern Med. 2021 Jun 8. doi: 10.7326/M21-0600.
    >> Share


  4. WISE J
    Covid-19: UK will offer third vaccine dose to severely immunosuppressed people.
    BMJ. 2021;374:n2160.
    >> Share

  5. LOOI MK
    Vaccine passports around the world.
    BMJ. 2021;374:n2142.
    >> Share

  6. DYER O
    Malaria: Combining vaccine with prophylaxis cuts child deaths by 73%, study finds.
    BMJ. 2021;374:n2137.
    >> Share

  7. How the world is (not) handling surplus doses and expiring vaccines.
    BMJ. 2021;374:n2127.
    >> Share

    Clin Infect Dis

    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  9. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  10. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

  11. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

    J Infect Dis

    Modern History of Cholera Vaccines and the Pivotal Role of icddr,b.
    J Infect Dis. 2021 Aug 28. pii: 6359024. doi: 10.1093.
    >> Share

  13. SAHA S, Saha SK
    Invasive Bacterial Vaccine-Preventable Disease Surveillance: Successes and Lessons Learned in Bangladesh for a Sustainable Path Forward.
    J Infect Dis. 2021;224.
    >> Share

  14. DUNN MG, Lessa FC, Sanchez J, Cordero R, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
    J Infect Dis. 2021;224.
    >> Share

  15. KABORE L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, et al
    Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys.
    J Infect Dis. 2021;224.
    >> Share

  16. YAMBA K, Mpabalwani E, Nakazwe R, Mulendele E, et al
    The Burden of Invasive Bacterial Disease and the Impact of 10-Valent Pneumococcal Conjugate Vaccine in Children <5 years hospitalized for Meningitis in Lusaka, Zambia, 2010-2019.
    J Infect Dis. 2021;224.
    >> Share

  17. SHRESTHA S, Stockdale LK, Gautam MC, Gurung M, et al
    Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
    J Infect Dis. 2021;224.
    >> Share

  18. NAKAMURA T, Cohen AL, Schwartz S, Mwenda JM, et al
    The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019.
    J Infect Dis. 2021;224.
    >> Share

  19. RABOBA JL, Rahajamanana VL, Andriatahirintsoa EPR, Razafindrakoto AC, et al
    Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar.
    J Infect Dis. 2021;224.
    >> Share

  20. KWAMBANA-ADAMS BA, Cohen AL, Hampton L, Nhantumbo AA, et al
    Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.
    J Infect Dis. 2021;224.
    >> Share

  21. FRANCOIS WATKINS LK, Milucky JL, McGee L, Sine St-Surin F, et al
    Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction.
    J Infect Dis. 2021;224.
    >> Share

  22. AHMED SS, Lessa FC, Coradin H, Sanchez J, et al
    High Prevalence of Vaccine-Type Infections Among Children with Pneumococcal Pneumonia and Effusion After 13-Valent Pneumococcal Conjugate Vaccine Introduction in the Dominican Republic.
    J Infect Dis. 2021;224.
    >> Share

  23. PECK ME, Hampton LM, Antoni S, Ogbuanu I, et al
    Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
    J Infect Dis. 2021;224.
    >> Share

    J Virol

  24. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    >> Share

  25. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    >> Share

  26. BALLMANN MZ, Raus S, Engelhart R, Kajan GL, et al
    Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development.
    J Virol. 2021 Sep 1:JVI0038721. doi: 10.1128/JVI.00387.
    >> Share


  27. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    >> Share

  28. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    >> Share

  29. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    >> Share

  30. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    >> Share


    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    >> Share

    MMWR Morb Mortal Wkly Rep

  32. MURTHY BP, Zell E, Saelee R, Murthy N, et al
    COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1206-1213.
    >> Share

  33. MATTHIAS J, Patrick S, Wiringa A, Pullman A, et al
    Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men's Conference - Illinois, June-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1223-1227.
    >> Share

  34. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1183-1190.
    >> Share

  35. LAM-HINE T, McCurdy SA, Santora L, Duncan L, et al
    Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1214-1219.
    >> Share

  36. DOYLE K, Teran RA, Reefhuis J, Kerins JL, et al
    Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1195-1200.
    >> Share

    N Engl J Med

  37. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    >> Share

  38. KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
    Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
    >> Share

    Nat Immunol

  39. ALSUWAIDI AR, Al Hosani FI, ElGhazali G, Al-Ramadi BK, et al
    The COVID-19 response in the United Arab Emirates: challenges and opportunities.
    Nat Immunol. 2021;22:1066-1067.
    >> Share

    Nat Med

  40. CHAGLA Z, Pai M
    COVID-19 boosters in rich nations will delay vaccines for all.
    Nat Med. 2021 Aug 31. pii: 10.1038/s41591-021-01494.
    >> Share


  41. PATEL KM, Malik AA, Lee A, Klotz M, et al
    COVID-19 Vaccine Uptake Among US Child Care Providers.
    Pediatrics. 2021 Aug 27. pii: peds.2021-053813. doi: 10.1542/peds.2021-053813.
    >> Share

    PLoS Comput Biol

  42. BAUER S, Contreras S, Dehning J, Linden M, et al
    Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves.
    PLoS Comput Biol. 2021;17:e1009288.
    >> Share

    PLoS One

  43. SUNOHARA S, Asakura T, Kimura T, Ozawa S, et al
    Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan.
    PLoS One. 2021;16:e0257107.
    >> Share

  44. ANGELO AT, Alemayehu DS, Dachew AM
    Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021.
    PLoS One. 2021;16:e0257109.
    >> Share

    Proc Natl Acad Sci U S A

  45. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


  46. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    >> Share


  47. DECKER MD, Garman PM, Hughes H, Yacovone MA, et al
    Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01074.
    >> Share

  48. KUROKAWA N, Robinson MK, Bernard C, Kawaguchi Y, et al
    Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01100.
    >> Share

  49. LEWIN BJ, Rodriguez J, Yang SJ, Tartof SY, et al
    Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01104.
    >> Share

  50. KANJI JN, Bailey A, Fenton J, Ling SH, et al
    Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
    >> Share

  51. MORAIS E, El Mouaddin N, Schuurman S, De A, et al
    Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01076.
    >> Share

  52. LIU S, Liu J
    Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
    >> Share

  53. MORIKAWA Y, Sakakibara H, Kimiya T, Obonai T, et al
    Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01011.
    >> Share

  54. AZIZ AB, Zaman K, Kim DR, Park JY, et al
    Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01096.
    >> Share

  55. BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
    Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
    >> Share

  56. NOWAK SA, Gidengil CA, Parker AM, Matthews LJ, et al
    Association among trust in health care providers, friends, and family, and vaccine hesitancy.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01068.
    >> Share

  57. HARPAZ R
    COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals?
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)00712.
    >> Share

  58. FOWLER A, Sampson M, Remaley AT, Chackerian B, et al
    A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
    Vaccine. 2021 Aug 30. pii: S0264-410X(21)01125.
    >> Share

  59. BATOOL R, Tahir Yousafzai M, Qureshi S, Ali M, et al
    Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01099.
    >> Share

  60. HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
    COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
    >> Share

  61. CAMPBELL JD, Pasetti MF, Oot L, Adam Z, et al
    Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01119.
    >> Share

  62. BAQUI AH, Koffi AK, McCollum ED, Roy AD, et al
    Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01116.
    >> Share

  63. PRELOG M, Almanzar G, Stern R, Robrade K, et al
    Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)01049.
    >> Share

  64. O'LORCAIN P, Cotter S, Walsh C
    Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
    >> Share

  65. ROTENBERG S, Downer MB, Cooper J
    Making COVID-19 vaccinations accessible for people with disabilities.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.
    >> Share

  66. MALTEZOU HC, Effraimidou E, Cassimos DC, Medic S, et al
    Vaccination programs for pregnant women in Europe, 2021.
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)01122.
    >> Share

  67. GORANDER S, Honda-Okubo Y, Backstrom M, Baldwin J, et al
    A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01098.
    >> Share

  68. SILCOCK R, Moghimi A, Perrett K, Crawford N, et al
    Subcutaneous nodule at the vaccine injection site - A case of mistaken identity.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01069.
    >> Share

    Virus Res

  69. HU J, Li G, Xi W, Cai L, et al
    Development of a subunit vaccine based on fiber2 and hexon against fowl adenovirus serotype 4.
    Virus Res. 2021 Aug 26:198552. doi: 10.1016/j.virusres.2021.198552.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016